Allan Camaisa serves as Executive at Calidi Biotherapeutics, Inc., where they oversee executive responsibilities. Since joining the company, Allan Camaisa has executed 2 insider transactions totaling $1.2K, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 12, 2025 involved selling 850 shares valued at $1.2K.
Allan Camaisa currently holds 76,952 shares of Calidi Biotherapeutics, Inc. (CLDI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Allan Camaisa has been a net seller of CLDI stock. They have purchased $0 and sold $1.2K worth of shares.
Allan Camaisa's most recent insider trade was on Dec 12, 2025, when they sold 850 shares at $1.46 per share.
Get notified when new Form 4 filings are submitted
| $1.15 |
| Discretionary |